Development of strains of Cryptococcus neoformans resistant to nystatin, amphotericin B, trichomycin and polymyxin B.
D000666:Amphotericin B / Q000494:pharmacology*; D000935:Antifungal Agents / Q000494:pharmacology*; D050260:Carbohydrate Metabolism; D003454:Cryptococcus / Q000187:drug effects* / Q000254:growth & development; D004352:Drug Resistance, Microbial; D005285:Fermentation; D008722:Methods; D009584:Nitrogen / Q000378:metabolism; D009761:Nystatin / Q000494:pharmacology*; D011113:Polymyxins / Q000494:pharmacology*
D000935:Antifungal Agents; D011113:Polymyxins; D009761:Nystatin; D000666:Amphotericin B; D009584:Nitrogen